RNA Based Therapeutics Market Report

China RNA Based Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Oct 11, 2023
  • PAGES：221
  • REPORT CODE：GMM1843579
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the RNA Based Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • ISIS pharmaceuticals

    • Quark Pharmaceuticals

    • Silence Therapeutics PLC

    • Dicerna Pharmaceuticals

    • Alnylam Pharmaceuticals

    • Cenix BioScience GmbH

    • Tekmira Pharmaceuticals Corp

    • Benitec Biopharma Limited

    By Type:

    • Microarrays

    • RNA Antisense

    • Purification

    • qRT-PCR

    • Labeling

    • Inhibition

    • RNA Interference (RNAi) Technologies

    By Application:

    • Cardiovascular

    • Oncology

    • Metabolic Disorders

    • Infectious Diseases

    • Kidney Diseases

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China RNA Based Therapeutics Market Overview 2018-2029

    • 1.1 China RNA Based Therapeutics Industry Development Overview

    • 1.2 China RNA Based Therapeutics Industry Development History

    • 1.3 China RNA Based Therapeutics Industry Market Size (2018-2029)

    • 1.4 China RNA Based Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China RNA Based Therapeutics Production Volume, Production Value and Growth Rate of Microarrays (2018-2029)

      • 1.4.2 China RNA Based Therapeutics Production Volume, Production Value and Growth Rate of RNA Antisense (2018-2029)

      • 1.4.3 China RNA Based Therapeutics Production Volume, Production Value and Growth Rate of Purification (2018-2029)

      • 1.4.4 China RNA Based Therapeutics Production Volume, Production Value and Growth Rate of qRT-PCR (2018-2029)

      • 1.4.5 China RNA Based Therapeutics Production Volume, Production Value and Growth Rate of Labeling (2018-2029)

      • 1.4.6 China RNA Based Therapeutics Production Volume, Production Value and Growth Rate of Inhibition (2018-2029)

      • 1.4.7 China RNA Based Therapeutics Production Volume, Production Value and Growth Rate of RNA Interference (RNAi) Technologies (2018-2029)

    • 1.5 China RNA Based Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China RNA Based Therapeutics Sales Volume, Sales Value and Growth Rate of Cardiovascular (2018-2029)

      • 1.5.2 China RNA Based Therapeutics Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

      • 1.5.3 China RNA Based Therapeutics Sales Volume, Sales Value and Growth Rate of Metabolic Disorders (2018-2029)

      • 1.5.4 China RNA Based Therapeutics Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

      • 1.5.5 China RNA Based Therapeutics Sales Volume, Sales Value and Growth Rate of Kidney Diseases (2018-2029)

    • 1.6 China RNA Based Therapeutics Market Analysis by Region

      • 1.6.1 North China RNA Based Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China RNA Based Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China RNA Based Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China RNA Based Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China RNA Based Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China RNA Based Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China RNA Based Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China RNA Based Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on RNA Based Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China RNA Based Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China RNA Based Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China RNA Based Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on RNA Based Therapeutics Industry Development

    Chapter 3 RNA Based TherapeuticsIndustry Chain Analysis

    • 3.1 RNA Based Therapeutics Industry Chain

    • 3.2 RNA Based Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the RNA Based Therapeutics Market

    • 3.3 RNA Based Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the RNA Based Therapeutics Market

    Chapter 4 China RNA Based Therapeutics Market, by Type

    • 4.1 China RNA Based Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China RNA Based Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China RNA Based Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China RNA Based Therapeutics Production Volume and Growth Rate of Microarrays

      • 4.5.2 China RNA Based Therapeutics Production Volume and Growth Rate of RNA Antisense

      • 4.5.3 China RNA Based Therapeutics Production Volume and Growth Rate of Purification

      • 4.5.4 China RNA Based Therapeutics Production Volume and Growth Rate of qRT-PCR

      • 4.5.5 China RNA Based Therapeutics Production Volume and Growth Rate of Labeling

      • 4.5.6 China RNA Based Therapeutics Production Volume and Growth Rate of Inhibition

      • 4.5.7 China RNA Based Therapeutics Production Volume and Growth Rate of RNA Interference (RNAi) Technologies

    Chapter 5 China RNA Based Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China RNA Based Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China RNA Based Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China RNA Based Therapeutics Market Size and Growth Rate of Cardiovascular

      • 5.5.2 China RNA Based Therapeutics Market Size and Growth Rate of Oncology

      • 5.5.3 China RNA Based Therapeutics Market Size and Growth Rate of Metabolic Disorders

      • 5.5.4 China RNA Based Therapeutics Market Size and Growth Rate of Infectious Diseases

      • 5.5.5 China RNA Based Therapeutics Market Size and Growth Rate of Kidney Diseases

    Chapter 6 China RNA Based Therapeutics Market, by Region

    • 6.1 China RNA Based Therapeutics Production Volume and Production Value, by Region

    • 6.2 China RNA Based Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China RNA Based Therapeutics Market Analysis

    • 7.1 North China RNA Based Therapeutics Market, by Type

    • 7.2 North China RNA Based Therapeutics Market, by Application

    Chapter 8 Central China RNA Based Therapeutics Market Analysis

    • 8.1 Central China RNA Based Therapeutics Market, by Type

    • 8.2 Central China RNA Based Therapeutics Market, by Application

    Chapter 9 South China RNA Based Therapeutics Market Analysis

    • 9.1 South China RNA Based Therapeutics Market, by Type

    • 9.2 South China RNA Based Therapeutics Market, by Application

    Chapter 10 East China RNA Based Therapeutics Market Analysis

    • 10.1 East China RNA Based Therapeutics Market, by Type

    • 10.2 East China RNA Based Therapeutics Market, by Application

    Chapter 11 Northeast China RNA Based Therapeutics Market Analysis

    • 11.1 Northeast China RNA Based Therapeutics Market, by Type

    • 11.2 Northeast China RNA Based Therapeutics Market, by Application

    Chapter 12 Southwest China RNA Based Therapeutics Market Analysis

    • 12.1 Southwest China RNA Based Therapeutics Market, by Type

    • 12.2 Southwest China RNA Based Therapeutics Market, by Application

    Chapter 13 Northwest China RNA Based Therapeutics Market Analysis

    • 13.1 Northwest China RNA Based Therapeutics Market, by Type

    • 13.2 Northwest China RNA Based Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 ISIS pharmaceuticals

        • 14.1.1 ISIS pharmaceuticals Company Profile

        • 14.1.2 ISIS pharmaceuticals RNA Based Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Quark Pharmaceuticals

        • 14.2.1 Quark Pharmaceuticals Company Profile

        • 14.2.2 Quark Pharmaceuticals RNA Based Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Silence Therapeutics PLC

        • 14.3.1 Silence Therapeutics PLC Company Profile

        • 14.3.2 Silence Therapeutics PLC RNA Based Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Dicerna Pharmaceuticals

        • 14.4.1 Dicerna Pharmaceuticals Company Profile

        • 14.4.2 Dicerna Pharmaceuticals RNA Based Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Alnylam Pharmaceuticals

        • 14.5.1 Alnylam Pharmaceuticals Company Profile

        • 14.5.2 Alnylam Pharmaceuticals RNA Based Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Cenix BioScience GmbH

        • 14.6.1 Cenix BioScience GmbH Company Profile

        • 14.6.2 Cenix BioScience GmbH RNA Based Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Tekmira Pharmaceuticals Corp

        • 14.7.1 Tekmira Pharmaceuticals Corp Company Profile

        • 14.7.2 Tekmira Pharmaceuticals Corp RNA Based Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Benitec Biopharma Limited

        • 14.8.1 Benitec Biopharma Limited Company Profile

        • 14.8.2 Benitec Biopharma Limited RNA Based Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 RNA Based Therapeutics Industry Research Conclusions

    • 15.2 RNA Based Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China RNA Based Therapeutics Industry Market Size (2018-2029)

    • Figure China RNA Based Therapeutics Production Volume, Production Value and Growth Rate of Microarrays (2018-2029)

    • Figure China RNA Based Therapeutics Production Volume, Production Value and Growth Rate of RNA Antisense (2018-2029)

    • Figure China RNA Based Therapeutics Production Volume, Production Value and Growth Rate of Purification (2018-2029)

    • Figure China RNA Based Therapeutics Production Volume, Production Value and Growth Rate of qRT-PCR (2018-2029)

    • Figure China RNA Based Therapeutics Production Volume, Production Value and Growth Rate of Labeling (2018-2029)

    • Figure China RNA Based Therapeutics Production Volume, Production Value and Growth Rate of Inhibition (2018-2029)

    • Figure China RNA Based Therapeutics Production Volume, Production Value and Growth Rate of RNA Interference (RNAi) Technologies (2018-2029)

    • Figure China RNA Based Therapeutics Sales Volume, Sales Value and Growth Rate of Cardiovascular (2018-2029)

    • Figure China RNA Based Therapeutics Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure China RNA Based Therapeutics Sales Volume, Sales Value and Growth Rate of Metabolic Disorders (2018-2029)

    • Figure China RNA Based Therapeutics Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

    • Figure China RNA Based Therapeutics Sales Volume, Sales Value and Growth Rate of Kidney Diseases (2018-2029)

    • Figure North China RNA Based Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China RNA Based Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China RNA Based Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China RNA Based Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China RNA Based Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China RNA Based Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China RNA Based Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure RNA Based Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China RNA Based Therapeutics Market Share by Type in 2018

    • Figure China RNA Based Therapeutics Market Share by Type in 2023

    • Figure China RNA Based Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China RNA Based Therapeutics Production Volume and Growth Rate of Microarrays (2018-2023)

    • Figure China RNA Based Therapeutics Production Volume and Growth Rate of RNA Antisense (2018-2023)

    • Figure China RNA Based Therapeutics Production Volume and Growth Rate of Purification (2018-2023)

    • Figure China RNA Based Therapeutics Production Volume and Growth Rate of qRT-PCR (2018-2023)

    • Figure China RNA Based Therapeutics Production Volume and Growth Rate of Labeling (2018-2023)

    • Figure China RNA Based Therapeutics Production Volume and Growth Rate of Inhibition (2018-2023)

    • Figure China RNA Based Therapeutics Production Volume and Growth Rate of RNA Interference (RNAi) Technologies (2018-2023)

    • Figure China RNA Based Therapeutics Market Share by Application in 2018

    • Figure China RNA Based Therapeutics Market Share by Application in 2023

    • Figure China RNA Based Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China RNA Based Therapeutics Market Size and Growth Rate of Cardiovascular (2018-2023)

    • Figure China RNA Based Therapeutics Market Size and Growth Rate of Oncology (2018-2023)

    • Figure China RNA Based Therapeutics Market Size and Growth Rate of Metabolic Disorders (2018-2023)

    • Figure China RNA Based Therapeutics Market Size and Growth Rate of Infectious Diseases (2018-2023)

    • Figure China RNA Based Therapeutics Market Size and Growth Rate of Kidney Diseases (2018-2023)

    • Table China RNA Based Therapeutics Production Volume by Region (2018-2023)

    • Table China RNA Based Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China RNA Based Therapeutics Production Volume Share by Region (2018-2023)

    • Table China RNA Based Therapeutics Production Value by Region (2018-2023)

    • Table China RNA Based Therapeutics Production Value Share by Region (2018-2023)

    • Figure China RNA Based Therapeutics Production Value Share by Region (2018-2023)

    • Table China RNA Based Therapeutics Sales Volume by Region (2018-2023)

    • Table China RNA Based Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China RNA Based Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China RNA Based Therapeutics Sales Value by Region (2018-2023)

    • Table China RNA Based Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China RNA Based Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China RNA Based Therapeutics Production Volume by Type (2018-2023)

    • Table North China RNA Based Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China RNA Based Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China RNA Based Therapeutics Sales Volume by Application (2018-2023)

    • Table North China RNA Based Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China RNA Based Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China RNA Based Therapeutics Production Volume by Type (2018-2023)

    • Table Central China RNA Based Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China RNA Based Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China RNA Based Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China RNA Based Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China RNA Based Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China RNA Based Therapeutics Production Volume by Type (2018-2023)

    • Table South China RNA Based Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China RNA Based Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China RNA Based Therapeutics Sales Volume by Application (2018-2023)

    • Table South China RNA Based Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China RNA Based Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China RNA Based Therapeutics Production Volume by Type (2018-2023)

    • Table East China RNA Based Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China RNA Based Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China RNA Based Therapeutics Sales Volume by Application (2018-2023)

    • Table East China RNA Based Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China RNA Based Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China RNA Based Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China RNA Based Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China RNA Based Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China RNA Based Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China RNA Based Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China RNA Based Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China RNA Based Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China RNA Based Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China RNA Based Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China RNA Based Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China RNA Based Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China RNA Based Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China RNA Based Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China RNA Based Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China RNA Based Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China RNA Based Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China RNA Based Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China RNA Based Therapeutics Sales Volume Share by Application (2018-2023)

    • Table ISIS pharmaceuticals Company Profile

    • Table ISIS pharmaceuticals RNA Based Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Quark Pharmaceuticals Company Profile

    • Table Quark Pharmaceuticals RNA Based Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Silence Therapeutics PLC Company Profile

    • Table Silence Therapeutics PLC RNA Based Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Dicerna Pharmaceuticals Company Profile

    • Table Dicerna Pharmaceuticals RNA Based Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Alnylam Pharmaceuticals Company Profile

    • Table Alnylam Pharmaceuticals RNA Based Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Cenix BioScience GmbH Company Profile

    • Table Cenix BioScience GmbH RNA Based Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Tekmira Pharmaceuticals Corp Company Profile

    • Table Tekmira Pharmaceuticals Corp RNA Based Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Benitec Biopharma Limited Company Profile

    • Table Benitec Biopharma Limited RNA Based Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US